Yicheng Yu

Key Laboratory Of Molecular Biology Of Crop Pathogens And Insects Of Zhejiang Province
Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The Microbial Community Succession Drives Stage-Specific Carbon Metabolic Shifts During Agaricus bisporus Fermentation: Multi-Omics Reveals CAZymes Dynamics and Lignocellulose Degradation Mechanisms.

The Microbial Community Succession Drives Stage-Specific Carbon Metabolic Shifts During Agaricus bisporus Fermentation: Multi-Omics Reveals CAZymes Dynamics and Lignocellulose Degradation Mechanisms.

Journal: Microorganisms

Published: November 05, 2025

Value of creatine kinase and creatinine as biomarkers in nusinersen-treated children with spinal muscular atrophy.

Value of creatine kinase and creatinine as biomarkers in nusinersen-treated children with spinal muscular atrophy.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: June 30, 2025

Plasma Neurofilament Light Chain as a Potential Biomarker of Presymptomatic Spinal Muscular Atrophy.

Plasma Neurofilament Light Chain as a Potential Biomarker of Presymptomatic Spinal Muscular Atrophy.

Journal: Muscle & nerve

Published: June 11, 2025

Association between serum copper concentration and body composition in children with spinal muscular atrophy: a cross-sectional study.

Association between serum copper concentration and body composition in children with spinal muscular atrophy: a cross-sectional study.

Journal: Asia Pacific journal of clinical nutrition

Published: January 19, 2025

Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study.

Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study.

Journal: Muscle & nerve

Published: October 08, 2024

Echocardiographic evaluation of left ventricular function in children with spinal muscular atrophy before and after nusinersen treatment.

Echocardiographic evaluation of left ventricular function in children with spinal muscular atrophy before and after nusinersen treatment.

Journal: Journal of the neurological sciences

Published: July 11, 2024

Longitudinal Efficacy of Nusinersen Treatment on Health-Related Quality of Life and Independence in Children With Later-Onset Spinal Muscular Atrophy.

Longitudinal Efficacy of Nusinersen Treatment on Health-Related Quality of Life and Independence in Children With Later-Onset Spinal Muscular Atrophy.

Journal: Muscle & nerve

Published: April 23, 2024

Analytical validation of the amplification refractory mutation system polymerase chain reaction-capillary electrophoresis assay to diagnose spinal muscular atrophy.

Analytical validation of the amplification refractory mutation system polymerase chain reaction-capillary electrophoresis assay to diagnose spinal muscular atrophy.

Journal: Clinical chemistry and laboratory medicine

Published: March 12, 2024

Impact of Nusinersen Treatment on the Independence and Mental Health of School-Aged Patients With Spinal Muscular Atrophy.

Impact of Nusinersen Treatment on the Independence and Mental Health of School-Aged Patients With Spinal Muscular Atrophy.

Journal: Pediatric neurology

Published: January 16, 2024

Optimized MLPA workflow for spinal muscular atrophy diagnosis: identification of a novel variant, NC_000005.10:g.(70919941_70927324)del in isolated exon 1 of SMN1 gene through long-range PCR.

Optimized MLPA workflow for spinal muscular atrophy diagnosis: identification of a novel variant, NC_000005.10:g.(70919941_70927324)del in isolated exon 1 of SMN1 gene through long-range PCR.

Journal: BMC neurology

Published: October 09, 2023

Value of plasma neurofilament light chain for monitoring efficacy in children with later-onset spinal muscular atrophy under nusinersen treatment.

Value of plasma neurofilament light chain for monitoring efficacy in children with later-onset spinal muscular atrophy under nusinersen treatment.

Journal: Clinical chemistry and laboratory medicine

Published: October 09, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026